Noncanonical IFN Signaling, Steroids, and STATs: A Probable Role of V-ATPase

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2019 Jul 6

PMID 31275057

Citations 10

Authors

Howard M Johnson

Ezra Noon-Song

Chulbul M Ahmed

Affiliations

Soon will be listed here.

Abstract

A small group of only seven transcription factors known as STATs (signal transducer and activator of transcription) are considered to be canonical determinants of specific gene activation for a plethora of ligand/receptor systems. The activation of STATs involves a family of four tyrosine kinases called JAK kinases. JAK1 and JAK2 activate STAT1 in the cytoplasm at the heterodimeric gamma interferon (IFN) receptor, while JAK1 and TYK2 activate STAT1 and STAT2 at the type I IFN heterodimeric receptor. The same STATs and JAKs are also involved in signaling by functionally different cytokines, growth factors, and hormones. Related to this, IFN-activated STAT1 binds to the IFN-activated sequence (GAS) element, but so do other STATs that are not involved in IFN signaling. Activated JAKs such as JAK2 and TYK2 are also involved in the epigenetics of nucleosome unwrapping for exposure of DNA to transcription. Furthermore, activated JAKs and STATs appear to function coordinately for specific gene activation. These complex events have not been addressed in canonical STAT signaling. Additionally, the function of noncoding enhancer RNAs, including their role in enhancer/promoter interaction is not addressed in the canonical STAT signaling model. In this perspective, we show that JAK/STAT signaling, involving membrane receptors, is essentially a variation of cytoplasmic nuclear receptor signaling. Focusing on IFN signaling, we showed that ligand, IFN receptor, the JAKs, and the STATs all undergo endocytosis and ATP-dependent nuclear translocation to promoters of genes specifically activated by IFNs. We argue here that the vacuolar ATPase (V-ATPase) proton pump probably plays a key role in endosomal membrane crossing by IFNs for receptor cytoplasmic binding. Signaling of nuclear receptors such as those of estrogen and dihydrotestosterone provides templates for making sense of the specificity of gene activation by closely related cytokines, which has implications for lymphocyte phenotypes.

Citing Articles

Regulation of bone homeostasis: signaling pathways and therapeutic targets.

Wu Z, Li W, Jiang K, Lin Z, Qian C, Wu M MedComm (2020). 2024; 5(8):e657.

PMID: 39049966 PMC: 11266958. DOI: 10.1002/mco2.657.

Disparate viral pandemics from COVID19 to monkeypox and beyond: a simple, effective and universal therapeutic approach hiding in plain sight.

Johnson H, Ahmed C Front Immunol. 2023; 14:1208828.

PMID: 38106428 PMC: 10722180. DOI: 10.3389/fimmu.2023.1208828.

The Foot-and-Mouth Disease Virus Lb Protease Cleaves Intracellular Transcription Factors STAT1 and STAT2 to Antagonize IFN-β-Induced Signaling.

Ma X, Luo Z, Song R, Nian X, Choudhury S, Ru Y J Immunol. 2022; 210(3):283-296.

PMID: 36548461 PMC: 9842942. DOI: 10.4049/jimmunol.2101042.

Individual and Synergistic Anti-Coronavirus Activities of SOCS1/3 Antagonist and Interferon α1 Peptides.

Ahmed C, Grams T, Bloom D, Johnson H, Lewin A Front Immunol. 2022; 13:902956.

PMID: 35799776 PMC: 9254576. DOI: 10.3389/fimmu.2022.902956.

Unique aspects of IFN-γ/STAT1 signaling in neurons.

Clark D, Begg L, Filiano A Immunol Rev. 2022; 311(1):187-204.

PMID: 35656941 PMC: 10120860. DOI: 10.1111/imr.13092.

References

KRAUSE C, Lunn C, Izotova L, Mirochnitchenko O, Kotenko S, Lundell D . Signaling by covalent heterodimers of interferon-gamma. Evidence for one-sided signaling in the active tetrameric receptor complex. J Biol Chem. 2000; 275(30):22995-3004. DOI: 10.1074/jbc.M909607199. View

Landar A, Curry B, Parker M, Digiacomo R, Indelicato S, Nagabhushan T . Design, characterization, and structure of a biologically active single-chain mutant of human IFN-gamma. J Mol Biol. 2000; 299(1):169-79. DOI: 10.1006/jmbi.2000.3734. View

Larkin 3rd J, Johnson H, Subramaniam P . Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-gamma receptor complex following activation by IFN-gamma. J Interferon Cytokine Res. 2000; 20(6):565-76. DOI: 10.1089/10799900050044769. View

Subramaniam P, Larkin 3rd J, Mujtaba M, Walter M, Johnson H . The COOH-terminal nuclear localization sequence of interferon gamma regulates STAT1 alpha nuclear translocation at an intracellular site. J Cell Sci. 2000; 113 ( Pt 15):2771-81. DOI: 10.1242/jcs.113.15.2771. View

Lin S, Makino K, Xia W, Matin A, Wen Y, Kwong K . Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol. 2001; 3(9):802-8. DOI: 10.1038/ncb0901-802. View

Subramaniam P, Torres B, Johnson H . So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors. Cytokine. 2001; 15(4):175-87. DOI: 10.1006/cyto.2001.0905. View

Subramaniam P, Green M, Larkin 3rd J, Torres B, Johnson H . Nuclear translocation of IFN-gamma is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence. J Interferon Cytokine Res. 2001; 21(11):951-9. DOI: 10.1089/107999001753289569. View

Brivanlou A, Darnell Jr J . Signal transduction and the control of gene expression. Science. 2002; 295(5556):813-8. DOI: 10.1126/science.1066355. View

Subramaniam P, Johnson H . Lipid microdomains are required sites for the selective endocytosis and nuclear translocation of IFN-gamma, its receptor chain IFN-gamma receptor-1, and the phosphorylation and nuclear translocation of STAT1alpha. J Immunol. 2002; 169(4):1959-69. DOI: 10.4049/jimmunol.169.4.1959. View

10.

Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore T . IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol. 2002; 4(1):63-8. DOI: 10.1038/ni873. View

11.

Kotenko S, Gallagher G, Baurin V, Lewis-Antes A, Shen M, Shah N . IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2002; 4(1):69-77. DOI: 10.1038/ni875. View

12.

Olsnes S, Klingenberg O, Wiedlocha A . Transport of exogenous growth factors and cytokines to the cytosol and to the nucleus. Physiol Rev. 2002; 83(1):163-82. DOI: 10.1152/physrev.00021.2002. View

13.

Carpenter G . Nuclear localization and possible functions of receptor tyrosine kinases. Curr Opin Cell Biol. 2003; 15(2):143-8. DOI: 10.1016/s0955-0674(03)00015-2. View

14.

Ahmed C, Burkhart M, Mujtaba M, Subramaniam P, Johnson H . The role of IFNgamma nuclear localization sequence in intracellular function. J Cell Sci. 2003; 116(Pt 15):3089-98. DOI: 10.1242/jcs.00528. View

15.

Johnson H, Subramaniam P, Olsnes S, Jans D . Trafficking and signaling pathways of nuclear localizing protein ligands and their receptors. Bioessays. 2004; 26(9):993-1004. DOI: 10.1002/bies.20086. View

16.

Platanias L . Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005; 5(5):375-86. DOI: 10.1038/nri1604. View

17.

Bryant D, Stow J . Nuclear translocation of cell-surface receptors: lessons from fibroblast growth factor. Traffic. 2005; 6(10):947-54. DOI: 10.1111/j.1600-0854.2005.00332.x. View

18.

Lu X, Levine R, Tong W, Wernig G, Pikman Y, Zarnegar S . Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation. Proc Natl Acad Sci U S A. 2005; 102(52):18962-7. PMC: 1323216. DOI: 10.1073/pnas.0509714102. View

19.

Carroll J, Brown M . Estrogen receptor target gene: an evolving concept. Mol Endocrinol. 2006; 20(8):1707-14. DOI: 10.1210/me.2005-0334. View

20.

Ahmed C, Johnson H . IFN-gamma and its receptor subunit IFNGR1 are recruited to the IFN-gamma-activated sequence element at the promoter site of IFN-gamma-activated genes: evidence of transactivational activity in IFNGR1. J Immunol. 2006; 177(1):315-21. DOI: 10.4049/jimmunol.177.1.315. View